Stanislav Kalinin

I obtained my PhD in Medicinal Chemistry from the Institute for Physiologically Active Compounds of the Russian Academy of Science in 2019. The PhD studies were carried out with Professor Mikhali Krasavin at Saint Petersburg State University. My research is focused on the design, synthesis and biological profiling of Carbonic anhydrase inhibitors. I am currently involved in a project related to the design of melanin-binding antiglaucoma drugs at the University of Eastern Finland.